Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Monday, July 22, 2024 | Back issues
Courthouse News Service Courthouse News Service

Diabetes drugs

SAN FRANCISCO — A federal court in California granted final approval to a nearly $454 million settlement in an antitrust action alleging manufacturers of a type 2 diabetes drug engaged in a “reverse-payment scheme and agreed not to compete with each other by delaying the introduction of a generic version of the drug for several years.”

Read the order here.  

Categories / Briefs, Business, Consumers, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...